Health & Science

With little concrete information, the city health department is trying to work out logistics.

Pharmaceutical company AstraZeneca made the announcement on Monday, saying that one dosing regimen showed the drug was 90% effective in preventing infection.

Deciding to gather or not can seem like just one more thing to deal with in this pandemic-disrupted year.

The experimental cocktail from the bio-tech company Regeneron is the same drug President Trump got when he was battling the coronavirus earlier this year.

Which test should you go for? Can you even schedule one? How long should you isolate before your test, and afterward? There’s a lot to consider.

PBS Newshour's John Yang reflects on his experience participating in Moderna's vaccine trial. "It started off with self-interest — I wanted to get the vaccine sooner."

The gift we all want — an end to pandemic life — is likely several months away. The just-imposed shutdowns will be with us until New Year’s.

As COVID-19 hospitalizations surge, new data released by the federal government show how many hospitals are struggling with staffing.

Positive coronavirus cases in 22 of the state’s 24 correctional institutions are putting advocates, and families with loved ones on the inside, on edge.

Pennsylvania Secretary of Health Rachel Levine said the federal government will distribute the antibodies to healthcare systems in the state.

The earliest shipments are expected to go to health care professionals and first responders first, with the vaccine likely becoming available to the public in April or May.

Since Nov. 12, the city Medical Examiner's office has confirmed three overdose deaths among restaurant and bar workers who thought they were using cocaine.

There are still dozens of options available, although many have long wait times and longer turnaround.

The 30 beds at the first site sometimes fill up, officials said, with people from shelters or those experiencing homelessness.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 in a study.